Global Fish Oil Market size was valued at USD 2.37 Bn in 2023 and is expected to reach USD 3.53 Bn by 2030, at a CAGR of 5.9 %.
The fish oil market is driven by increasing demand for omega-3 fatty acids across food, pharmaceuticals, and dietary supplements. Leading players such as BASF, DSM-Firmenich, Croda International, Omega Protein, and GC Rieber, focus on sustainability and product innovation. Companies are leveraging eco-friendly practices like sustainable fishing and marine ecosystem preservation to enhance their market presence. Innovation in omega-3 formulations, such as concentrated and purified fish oils for specific health benefits, adds to the competitive dynamics. Additionally, partnerships, acquisitions, and regional expansion are key strategies employed to capture a larger share of this growing market.
BASF
BASF Corporation, headquartered in Florham Park, New Jersey, focuses on creating a sustainable future by combining economic success with environmental protection and social responsibility. With around 112,000 employees globally, BASF operates across six segments namely Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition and Care, and Agricultural Solutions, generating €68.9 billion in sales in 2023. Their Omega Oil 1812 TG Gold, rich in omega-3 fatty acids, serves the food, nutrition, healthcare, and pharmaceutical markets, with applications in cooking oils, dairy, meat, poultry, and seafood. BASF prioritizes sustainability by collaborating with fish oil suppliers to meet environmental and social responsibility standards. Their omega-3 products cater to dietary supplements and functional foods, enhancing overall health benefits. The company continuously invests in research and development to improve product efficacy.
DSM-Firmenich
DSM-Firmenich is a prominent player in the fish oil market, offering science-based and sustainable solutions for human and animal nutrition. The company supports product development from concept through research, leveraging its expertise in food science to create targeted solutions that enhance flavor, texture, and nutrition. In animal nutrition, DSM-Firmenich focuses on microbiome interactions, immunology, and nutrition research to deliver innovative solutions. The company addresses sustainability challenges in omega-3 production, particularly with traditional marine sources, by pioneering algal-sourced omega-3s. These solutions offer a more sustainable alternative, with untapped potential to shape the future of the omega-3 market and drive industry innovation.
AlgiSys BioSciences, Inc
AlgiSys, headquartered in Cleveland, Ohio, fish oil market leader, specializing in sustainable algal-sourced EPA omega-3 oils. AlgiSys is dedicated to preserving natural resources, enhancing human health, and operating with a triple bottom line: People, Profits, and Planet. The company markets its algal EPA omega-3 oils and plant-based protein using a natural and sustainable fermentation process. Initially targeting the supplement, human, animal, and pet nutrition markets, AlgiSys plans to expand into the pharmaceutical, food & beverage, and cosmetics sectors. While DHA production through microalgae fermentation is well-established, AlgiSys has developed the first commercial process for algal EPA production, positioning itself to meet the growing global demand for omega-3 and high-protein biomass products with innovative biotechnology.
In November 2021, AlgiSys BioSciences, Inc. Raised funding of USD 45 Million. This funding will fuel the company's initial commercial strategies, which are propelled by increasing global demand for EPA omega-3 fish oil substitutes.
Recent development
• In March 2024, Pelagia announced the acquisition of the UK-based seafood trading firm Ideal Foods Limited. Pelagia intends to create cooperation and teamwork with Ideal Foods in order to boost its global supply chain and reinforce its market position, all while persisting in advancing and utilizing seafood by-products.
• In June 2024, GC Rieber VivoMega opened a new omega-3 manufacturing facility in Norway. The plant, which will operate on 100% renewable energy, is expected to double the current output of triglyceride marine omega-3s and vegan algal oils, addressing the rising demand for omega-3 supplements.
• In September 2023, Aker BioMarine and Swisse collaborated to launch an innovative product in Australia's Listed Assessed medicine category. The approval of Swisse Ultiboost High Strength Krill Oil, containing Aker BioMarine's Superba Boost Krill oil, allows it to be listed on the Australia Register of Therapeutic Goods (ARTG) under AUST L(A) 417392.
• In March 2023, Global agribusiness giant Cargill teamed up with Spanish alternative fat company Cubiq Foods to develop novel fat technology. As part of the partnership, Cargill said it would now have access to Cubiq Food's technologies to help customers develop plant-based alternative foods.